Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4789955
Max Phase: Preclinical
Molecular Formula: C24H15NO6S
Molecular Weight: 445.45
Molecule Type: Unknown
Associated Items:
ID: ALA4789955
Max Phase: Preclinical
Molecular Formula: C24H15NO6S
Molecular Weight: 445.45
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1c2ccccc2C(=O)c2c1cc(NS(=O)(=O)c1ccc3ccccc3c1)c(O)c2O
Standard InChI: InChI=1S/C24H15NO6S/c26-21-16-7-3-4-8-17(16)22(27)20-18(21)12-19(23(28)24(20)29)25-32(30,31)15-10-9-13-5-1-2-6-14(13)11-15/h1-12,25,28-29H
Standard InChI Key: OIGZSURJFXLNOJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 445.45 | Molecular Weight (Monoisotopic): 445.0620 | AlogP: 3.83 | #Rotatable Bonds: 3 |
Polar Surface Area: 120.77 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 6.60 | CX Basic pKa: | CX LogP: 5.09 | CX LogD: 3.76 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.36 | Np Likeness Score: -0.24 |
1. Huang K,Jiang L,Liang R,Li H,Ruan X,Shan C,Ye D,Zhou L. (2019) Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment., 168 [PMID:30798052] [10.1016/j.ejmech.2019.01.085] |
Source(1):